In This Article:
In the wake of heightened global trade tensions and significant market declines, investors are navigating a complex landscape marked by uncertainty and volatility. Despite these challenges, opportunities may exist in stocks that appear undervalued relative to their intrinsic value, offering potential for long-term growth as markets stabilize.
Top 10 Undervalued Stocks Based On Cash Flows
Name | Current Price | Fair Value (Est) | Discount (Est) |
Suzhou TFC Optical Communication (SZSE:300394) | CN¥63.56 | CN¥126.06 | 49.6% |
Micro Systemation (OM:MSAB B) | SEK48.90 | SEK97.74 | 50% |
Mandom (TSE:4917) | ¥1228.00 | ¥2452.46 | 49.9% |
Aoyama Zaisan Networks CompanyLimited (TSE:8929) | ¥1640.00 | ¥3266.59 | 49.8% |
Zinzino (OM:ZZ B) | SEK139.80 | SEK278.41 | 49.8% |
LPP (WSE:LPP) | PLN15365.00 | PLN30699.29 | 49.9% |
América Móvil. de (BMV:AMX B) | MX$14.50 | MX$28.72 | 49.5% |
Fervi (BIT:FVI) | €14.70 | €29.13 | 49.5% |
Qi An Xin Technology Group (SHSE:688561) | CN¥28.10 | CN¥55.82 | 49.7% |
TORIDOLL Holdings (TSE:3397) | ¥3718.00 | ¥7379.94 | 49.6% |
Let's uncover some gems from our specialized screener.
Fertiglobe
Overview: Fertiglobe plc is a global producer and seller of nitrogen-based products with a market capitalization of AED17.68 billion.
Operations: The company's revenue is primarily derived from the production and marketing of owned produced volumes, totaling $1.90 billion, with an additional $113 million from third-party trading.
Estimated Discount To Fair Value: 21.5%
Fertiglobe is trading at AED2.13, significantly below its fair value estimate of AED2.71, indicating it may be undervalued based on discounted cash flows. Despite revenue growth forecasts of 6.9% annually and strong earnings growth expectations of 16%, interest payments are not well covered by earnings, and profit margins have declined from last year. Recent financials show a decrease in annual sales and net income, with dividends totaling USD 275 million for the year ended December 2024.
-
Our growth report here indicates Fertiglobe may be poised for an improving outlook.
-
Get an in-depth perspective on Fertiglobe's balance sheet by reading our health report here.
Angelalign Technology
Overview: Angelalign Technology Inc. is an investment holding company that researches, develops, designs, manufactures, and markets clear aligner treatment solutions in the People’s Republic of China with a market cap of HK$9.44 billion.
Operations: The company's revenue is primarily derived from its Dental Equipment & Supplies segment, totaling $268.79 million.
Estimated Discount To Fair Value: 12.8%